Vor Biopharma Inc. (VOR)

Business: Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients.

IPO Date: 05-Feb-2021

Pres, CEO & Director: Dr. Robert Ang M.B.A., M.D., MBBS

Chief Scientific Officer: Dr. Tirtha Chakraborty Ph.D.

Listing: NASDAQ: VOR

Country: United States

Headquarters: Cambridge, MA

Website: https://www.vorbio.com

Market cap: $209.42 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-77.91 Mln

Cash: $181.62 Mln

Total Debt: $28.96 Mln

Insider's Holding: 10.65%

Liquidity: Low

52 Week range: $3.85 - 20.90

Shares outstanding: 37,598,400